<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39201353</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>16</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>VEGF Polymorphisms (<i>VEGF-936 C/T</i>, <i>VEGF-634 G/C</i> and <i>VEGF-2578 C/A</i>) and Cardiovascular Implications in Long COVID Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">8667</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25168667</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has raised awareness of the virus's long-term non-pulmonary consequences. This study examined the relationship between genetic polymorphisms of VEGF and cardiac dysfunction and subclinical atherosclerosis in patients recovering from COVID-19. This study included 67 patients previously diagnosed with COVID-19. <i>VEGF-936C/T, VEGF-634G/C</i>, and <i>VEGF-2578C/A</i> statuses were determined. Conventional echocardiography and arterial parameters assessments were performed at inclusion and at six months after the first assessment. For <i>VEGF-936C/T</i>, dominant and over-dominant models showed a significant increase in ejection fraction at six months after COVID (<i>p</i> = 0.044 and 0.048) and was also a predictive independent factor for the augmentation index (&#x3b2; = 3.07; <i>p</i> = 0.024). The dominant model showed a rise in RV-RA gradient (3.702 mmHg) (<i>p</i> = 0.028 95% CI: 0.040-7.363), with the over-dominant model indicating a greater difference (4.254 mmHg) (<i>p</i> = 0.025 95% CI: 0.624-7.884). The findings for <i>VEGF-634G/C</i> were not statistically significant, except for a difference in TAPSE during initial evaluation, using the codominant model. For <i>VEGF-2578C/A</i>, a difference in ventricular filling pressure (E/E'ratio) was best described under the recessive model. Our research suggests that the <i>VEG-936C/T</i> genotype may impact the baseline level and subsequent changes in cardiac function and subclinical atherosclerosis. These findings offer valuable insights into the complex correlation between genetic polymorphisms and cardiovascular disfunction in long COVID patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cozma</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, "Iuliu Ha&#x21b;ieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sitar-T&#x103;u&#x21b;</LastName><ForeName>Adela Viviana</ForeName><Initials>AV</Initials><Identifier Source="ORCID">0000-0001-8590-4583</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, "Iuliu Ha&#x21b;ieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Or&#x103;&#x219;an</LastName><ForeName>Olga Hilda</ForeName><Initials>OH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, "Iuliu Ha&#x21b;ieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briciu</LastName><ForeName>Violeta</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Epidemiology, "Iuliu Ha&#x21b;ieganu" University of Medicine and Pharmacy, 400348 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leucu&#x21b;a</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics and Biostatistics, "Iuliu Ha&#x163;ieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spori&#x219;</LastName><ForeName>Nicolae-Dan</ForeName><Initials>ND</Initials><Identifier Source="ORCID">0000-0001-5584-564X</Identifier><AffiliationInfo><Affiliation>Department of Medical Oncology, Prof. Dr. I. Chiricu&#x21b;a Oncology Institute, 400015 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laz&#x103;r</LastName><ForeName>Andrada-Luciana</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0001-8428-8088</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, "Iuliu Ha&#x21b;ieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#x103;linescu</LastName><ForeName>Toma-Vlad</ForeName><Initials>TV</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, "Iuliu Ha&#x21b;ieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganea</LastName><ForeName>Andreea-Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, "Iuliu Ha&#x21b;ieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spori&#x219;</LastName><ForeName>Bianca Mihaela</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Regional Institute of Gastroenterology "Prof. Dr. Octavian Fodor", 400394 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlad</LastName><ForeName>C&#x103;lin Vasile</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, "Iuliu Ha&#x21b;ieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lup&#x219;e</LastName><ForeName>Mihaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, "Iuliu Ha&#x21b;ieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x21a;&#xe2;ru</LastName><ForeName>M&#x103;d&#x103;lina-Gabriela</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Regional Institute of Gastroenterology "Prof. Dr. Octavian Fodor", 400394 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Procopciuc</LastName><ForeName>Lucia Maria</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-4738-5775</Identifier><AffiliationInfo><Affiliation>Department of Medical Biochemistry, "Iuliu Ha&#x163;ieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C467484">VEGFA protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042461" MajorTopicYN="Y">Vascular Endothelial Growth Factor A</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050197" MajorTopicYN="N">Atherosclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">VEGF polymorphism</Keyword><Keyword MajorTopicYN="N">cardiovascular</Keyword><Keyword MajorTopicYN="N">ejection fraction</Keyword><Keyword MajorTopicYN="N">pulse wave analysis</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39201353</ArticleId><ArticleId IdType="pmc">PMC11354396</ArticleId><ArticleId IdType="doi">10.3390/ijms25168667</ArticleId><ArticleId IdType="pii">ijms25168667</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Gao Y., Di L., Ma H., Mei B., Zhang J., Wang A., Feng K., Yang L., Chen Z. Characteristics of 1738 Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China. Disaster Med. Public Health Prep. 2022;16:2453&#x2013;2457. doi: 10.1017/dmp.2021.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/dmp.2021.129</ArticleId><ArticleId IdType="pmc">PMC8193190</ArticleId><ArticleId IdType="pubmed">33926610</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel B.V., Arachchillage D.J., Ridge C.A., Bianchi P., Doyle J.F., Garfield B., Ledot S., Morgan C., Passariello M., Price S., et al. Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations. Am. J. Respir. Crit. Care Med. 2020;202:690&#x2013;699. doi: 10.1164/rccm.202004-1412OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202004-1412OC</ArticleId><ArticleId IdType="pmc">PMC7462405</ArticleId><ArticleId IdType="pubmed">32667207</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Jonigk D. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.W., Byzova T.V. Oxidative stress in angiogenesis and vascular disease. Blood. 2014;123:625&#x2013;631. doi: 10.1182/blood-2013-09-512749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-09-512749</ArticleId><ArticleId IdType="pmc">PMC3907751</ArticleId><ArticleId IdType="pubmed">24300855</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P., Singh M., Khinda R., Valecha S., Kumar N., Singh S., Mastana S. Genetic Scores of eNOS, ACE and VEGFA Genes Are Predictive of Endothelial Dysfunction Associated Osteoporosis in Postmenopausal Women. Int. J. Environ. Res. Public Health. 2021;18:972. doi: 10.3390/ijerph18030972.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18030972</ArticleId><ArticleId IdType="pmc">PMC7908366</ArticleId><ArticleId IdType="pubmed">33499313</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., Meng L., Jiang J., Wu X. Vascular endothelial growth factor gene polymorphisms and coronary heart disease: A systematic review and meta-analysis. Growth Factors. 2018;36:153&#x2013;163. doi: 10.1080/08977194.2018.1477141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08977194.2018.1477141</ArticleId><ArticleId IdType="pubmed">30317903</ArticleId></ArticleIdList></Reference><Reference><Citation>Le T.H.V., Kwon S.M. Vascular Endothelial Growth Factor Biology and Its Potential as a Therapeutic Target in Rheumatic Diseases. Int. J. Mol. Sci. 2021;22:5387. doi: 10.3390/ijms22105387.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22105387</ArticleId><ArticleId IdType="pmc">PMC8161097</ArticleId><ArticleId IdType="pubmed">34065409</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsurumi Y., Murohara T., Krasinski K., Chen D., Witzenbichler B., Kearney M., Couffinhal T., Isner J.M. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat. Med. 1997;3:879&#x2013;886. doi: 10.1038/nm0897-879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0897-879</ArticleId><ArticleId IdType="pubmed">9256279</ArticleId></ArticleIdList></Reference><Reference><Citation>Apte R.S., Chen D.S., Ferrara N. VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019;176:1248&#x2013;1264. doi: 10.1016/j.cell.2019.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.01.021</ArticleId><ArticleId IdType="pmc">PMC6410740</ArticleId><ArticleId IdType="pubmed">30849371</ArticleId></ArticleIdList></Reference><Reference><Citation>Venables J.P. Unbalanced alternative splicing and its significance in cancer. BioEssays News Rev. Mol. Cell Dev. Biol. 2006;28:378&#x2013;386. doi: 10.1002/bies.20390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.20390</ArticleId><ArticleId IdType="pubmed">16547952</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Cross D.F., Ollerenshaw M., Millward B.A., Demaine A.G. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J. Diabetes Its Complicat. 2003;17:1&#x2013;6. doi: 10.1016/S1056-8727(02)00181-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1056-8727(02)00181-2</ArticleId><ArticleId IdType="pubmed">12505748</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong P. Association of vascular endothelial growth factor expression and polymorphisms with the risk of gestational diabetes mellitus. J. Clin. Lab. Anal. 2019;33:e22686. doi: 10.1002/jcla.22686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.22686</ArticleId><ArticleId IdType="pmc">PMC6818619</ArticleId><ArticleId IdType="pubmed">30350881</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrypnik D., Mostowska A., Jagodzi&#x144;ski P.P., Bogda&#x144;ski P. Association of rs699947 (&#x2212;2578 C/A) and rs2010963 (&#x2212;634 G/C) Single Nucleotide Polymorphisms of the VEGF Gene, VEGF-A and Leptin Serum Level, and Cardiovascular Risk in Patients with Excess Body Mass: A Case-Control Study. J. Clin. Med. 2020;9:469. doi: 10.3390/jcm9020469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020469</ArticleId><ArticleId IdType="pmc">PMC7073834</ArticleId><ArticleId IdType="pubmed">32046348</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleda S., De Haro J., Varela C., Esparza L., Ferruelo A., Acin F. Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patients. Diabetes Vasc. Dis. Res. 2012;9:68&#x2013;74. doi: 10.1177/1479164111426162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1479164111426162</ArticleId><ArticleId IdType="pubmed">22064697</ArticleId></ArticleIdList></Reference><Reference><Citation>Verheul H.M., Hoekman K., Lupu F., Broxterman H.J., Van Der Valk P., Kakkar A.K., Pinedo H.M. Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin. Cancer Res. 2000;6:166&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">10656446</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins. Endocr. Rev. 1992;13:18&#x2013;32. doi: 10.1210/edrv-13-1-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/edrv-13-1-18</ArticleId><ArticleId IdType="pubmed">1372863</ArticleId></ArticleIdList></Reference><Reference><Citation>Minchenko A., Bauer T., Salceda S., Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab. Investig. J. Tech. Methods Pathol. 1994;71:374&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">7933988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O&#x2019;Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439&#x2013;442. doi: 10.1038/380439a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/380439a0</ArticleId><ArticleId IdType="pubmed">8602242</ArticleId></ArticleIdList></Reference><Reference><Citation>Dvorak H.F. Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2002;20:4368&#x2013;4380. doi: 10.1200/JCO.2002.10.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2002.10.088</ArticleId><ArticleId IdType="pubmed">12409337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim I., Moon S.-O., Kim S.H., Kim H.J., Koh Y.S., Koh G.Y. Vascular Endothelial Growth Factor Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin through Nuclear Factor-&#x3ba;B Activation in Endothelial Cells. J. Biol. Chem. 2001;276:7614&#x2013;7620. doi: 10.1074/jbc.M009705200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M009705200</ArticleId><ArticleId IdType="pubmed">11108718</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoli M.M., Amiri P., Alborzi A., Larijani B., Saba S., Tavakkoly-Bazzaz J. VEGF gene mRNA expression in patients with coronary artery disease. Mol. Biol. Rep. 2012;39:8595&#x2013;8599. doi: 10.1007/s11033-012-1713-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-012-1713-x</ArticleId><ArticleId IdType="pubmed">22711306</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Q., Li Y., Duan C., Zhang W., Guo X. Further evidence for the contribution of the vascular endothelial growth factor gene in coronary artery disease susceptibility. Gene. 2013;521:217&#x2013;221. doi: 10.1016/j.gene.2013.03.091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2013.03.091</ArticleId><ArticleId IdType="pubmed">23545315</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma W.-Q., Wang Y., Han X.-Q., Zhu Y., Liu N.-F. Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: A meta&#x2013;analysis. BMC Med. Genet. 2018;19:108. doi: 10.1186/s12881-018-0628-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12881-018-0628-3</ArticleId><ArticleId IdType="pmc">PMC6031176</ArticleId><ArticleId IdType="pubmed">29973139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa H., Suefuji H., Soejima H., Nishiyama K., Misumi K., Takazoe K., Miyamoto S., Kajiwara I., Sumida H., Sakamoto T., et al. Increased Blood Vascular Endothelial Growth Factor Levels in Patients with Acute Myocardial Infarction. Cardiology. 2000;93:93&#x2013;99. doi: 10.1159/000007008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000007008</ArticleId><ArticleId IdType="pubmed">10894913</ArticleId></ArticleIdList></Reference><Reference><Citation>Soeki T., Tamura Y., Shinohara H., Tanaka H., Bando K., Fukuda N. Serial Changes in Serum VEGF and HGF in Patients with Acute Myocardial Infarction. Cardiology. 2000;93:168&#x2013;174. doi: 10.1159/000007022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000007022</ArticleId><ArticleId IdType="pubmed">10965088</ArticleId></ArticleIdList></Reference><Reference><Citation>Er&#x17e;en B., &#x160;ilar M., &#x160;abovi&#x10d; M. Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden. BMC Cardiovasc. Disord. 2014;14:166. doi: 10.1186/1471-2261-14-166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2261-14-166</ArticleId><ArticleId IdType="pmc">PMC4251840</ArticleId><ArticleId IdType="pubmed">25417001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kangas-Kontio T., Tapanainen J.M., Huikuri H., Savolainen E.R., P&#xe4;iv&#xe4;nsalo M., Kauma H., Kakko S. Variation in the vascular endothelial growth factor gene, carotid intima-media thickness and the risk of acute myocardial infarction. Scand. J. Clin. Lab. Investig. 2009;69:335&#x2013;343. doi: 10.1080/00365510802607520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365510802607520</ArticleId><ArticleId IdType="pubmed">19089753</ArticleId></ArticleIdList></Reference><Reference><Citation>Nezu T., Hosomi N., Aoki S., Matsumoto M. Carotid Intima-Media Thickness for Atherosclerosis. J. Atheroscler. Thromb. 2016;23:18&#x2013;31. doi: 10.5551/jat.31989.</Citation><ArticleIdList><ArticleId IdType="doi">10.5551/jat.31989</ArticleId><ArticleId IdType="pubmed">26460381</ArticleId></ArticleIdList></Reference><Reference><Citation>Davignon J., Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109((Suppl. S1)):III27&#x2013;III32. doi: 10.1161/01.CIR.0000131515.03336.f8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000131515.03336.f8</ArticleId><ArticleId IdType="pubmed">15198963</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffensen K., Waldstr&#xf8;m M., Brandslund I., Jakobsen A. The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer. Gynecol. Oncol. 2010;117:109&#x2013;116. doi: 10.1016/j.ygyno.2009.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2009.11.011</ArticleId><ArticleId IdType="pubmed">20056267</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovas A., Osiaevi I., Buscher K., Sackarnd J., Tepasse P.-R., Fobker M., K&#xfc;hn J., Braune S., G&#xf6;bel U., Th&#xf6;lking G., et al. Microvascular dysfunction in COVID-19: The MYSTIC study. Angiogenesis. 2021;24:145&#x2013;157. doi: 10.1007/s10456-020-09753-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-020-09753-7</ArticleId><ArticleId IdType="pmc">PMC7556767</ArticleId><ArticleId IdType="pubmed">33058027</ArticleId></ArticleIdList></Reference><Reference><Citation>Josuttis D., Schwedler C., Heymann G., G&#xfc;mbel D., Schmittner M.D., Kruse M., Hoppe B. Vascular Endothelial Growth Factor as Potential Biomarker for COVID-19 Severity. J. Intensiv. Care Med. 2023;38:1165&#x2013;1173. doi: 10.1177/08850666231186787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666231186787</ArticleId><ArticleId IdType="pmc">PMC10345830</ArticleId><ArticleId IdType="pubmed">37448220</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahebnasagh A., Nabavi S.M., Kashani H.R.K., Aghaabdollahian S., Habtemariam S., Rezabakhsh A. Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients. Pt BInt. Immunopharmacol. 2021;101:108257. doi: 10.1016/j.intimp.2021.108257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108257</ArticleId><ArticleId IdType="pmc">PMC8519896</ArticleId><ArticleId IdType="pubmed">34673299</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S.-W., Ilyas I., Weng J.-P. Endothelial dysfunction in COVID-19: An overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol. Sin. 2023;44:695&#x2013;709. doi: 10.1038/s41401-022-00998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodor A., Tiperciuc B., Login C., Orasan O.H., Lazar A.L., Buchman C., Cozma A. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets. Oxidative Med. Cell. Longev. 2021;2021:8671713. doi: 10.1155/2021/8671713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8671713</ArticleId><ArticleId IdType="pmc">PMC8397545</ArticleId><ArticleId IdType="pubmed">34457119</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira M.R., Back G.D., Goulart C.d.L., Domingos B.C., Arena R., Borghi-Silva A. Endothelial function provides early prognostic information in patients with COVID-19: A cohort study. Respir. Med. 2021;185:106469. doi: 10.1016/j.rmed.2021.106469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106469</ArticleId><ArticleId IdType="pmc">PMC8141349</ArticleId><ArticleId IdType="pubmed">34175806</ArticleId></ArticleIdList></Reference><Reference><Citation>Araujo-Silva C.A., Marcos A.A.A., Marinho P.M., Branco A.M.C., Roque A., Romano A.C., Matuoka M.L., Farah M., Burnier M., Moraes N.F., et al. Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19. JAMA Ophthalmol. 2021;139:1015&#x2013;1021. doi: 10.1001/jamaophthalmol.2021.2795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaophthalmol.2021.2795</ArticleId><ArticleId IdType="pmc">PMC8323055</ArticleId><ArticleId IdType="pubmed">34323931</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A., Bryce C., Grimes Z., Gordon R.E., Reidy J., Lednicky J., Sordillo E.M., Fowkes M. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J. Med. Virol. 2020;92:699&#x2013;702. doi: 10.1002/jmv.25915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25915</ArticleId><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Egas D., Guadalupe J.J., Prado-Vivar B., Becerra-Wong M., M&#xe1;rquez S., Castillo S., Latta J., Rodriguez F., Escorza G., Trueba G., et al. SARS-CoV-2 detection and sequencing in heart tissue associated with myocarditis and persistent arrhythmia: A case report. IDCases. 2021;25:e01187. doi: 10.1016/j.idcr.2021.e01187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2021.e01187</ArticleId><ArticleId IdType="pmc">PMC8192838</ArticleId><ArticleId IdType="pubmed">34136351</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfieri L., Franceschetti L., Frisoni P., Bonato O., Radaelli D., Bonuccelli D., D&#x2019;errico S., Neri M. Cardiac SARS-CoV-2 Infection, Involvement of Cytokines in Postmortem Immunohistochemical Study. Diagnostics. 2024;14:787. doi: 10.3390/diagnostics14080787.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics14080787</ArticleId><ArticleId IdType="pmc">PMC11049034</ArticleId><ArticleId IdType="pubmed">38667433</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne R.A., Webb D.J. Arterial blood pressure and stiffness in hypertension: Is arterial structure important? Hypertension. 2006;48:366&#x2013;367. doi: 10.1161/01.HYP.0000237668.31786.1f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000237668.31786.1f</ArticleId><ArticleId IdType="pubmed">16908759</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadruz W., Shah A.M., Solomon S.D. Diastolic Dysfunction and Hypertension. Med. Clin. North Am. 2017;101:7&#x2013;17. doi: 10.1016/j.mcna.2016.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcna.2016.08.013</ArticleId><ArticleId IdType="pubmed">27884237</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Management of COVID-19: Living Guideline. World Health Organization; Geneva, Switzerland: 2022.  [(accessed on 30 December 2023)].  WHO Guidelines Approved by the Guidelines Review Committee. Available online:  http://www.ncbi.nlm.nih.gov/books/NBK582435/</Citation><ArticleIdList><ArticleId IdType="pubmed">35917394</ArticleId></ArticleIdList></Reference><Reference><Citation>Papazoglou D., Galazios G., Koukourakis M.I., Kontomanolis E.N., Maltezos E. Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery. Acta Obstet. Gynecol. Scand. 2004;83:461&#x2013;465. doi: 10.1111/j.0001-6349.2004.00403.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0001-6349.2004.00403.x</ArticleId><ArticleId IdType="pubmed">15059159</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Li Y., Zhao J., Sun D.-L., Duan Y.-N., Wang N., Zhou R.-M., Kang S. Association of polymorphisms -1154G/A and -2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women. Hum. Reprod. Oxf. Engl. 2009;24:2660&#x2013;2666. doi: 10.1093/humrep/dep208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/dep208</ArticleId><ArticleId IdType="pubmed">19531502</ArticleId></ArticleIdList></Reference><Reference><Citation>Procopciuc L.M., Caracostea G., Zaharie G., Stamatian F. Maternal/newborn VEGF-C936T interaction and its influence on the risk, severity and prognosis of preeclampsia, as well as on the maternal angiogenic profile. J. Matern. Fetal. Neonatal. Med. 2014;27:1754&#x2013;1760. doi: 10.3109/14767058.2014.942625.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14767058.2014.942625</ArticleId><ArticleId IdType="pubmed">25007988</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J.R., Armengol L., Sol&#xe9; X., Guin&#xf3; E., Mercader J.M., Estivill X., Moreno V. SNPassoc: An R package to perform whole genome association studies. Bioinformatics. 2007;23:654&#x2013;655. doi: 10.1093/bioinformatics/btm025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btm025</ArticleId><ArticleId IdType="pubmed">17267436</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., Poland G.A. Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous. Am. J. Hum. Genet. 2002;70:425&#x2013;434. doi: 10.1086/338688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/338688</ArticleId><ArticleId IdType="pmc">PMC384917</ArticleId><ArticleId IdType="pubmed">11791212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinnwell J.P., Schaid D.J. haplo.stats: Statistical Analysis of Haplotypes with Traits and Covariates when Linkage Phase Is Am-biguous.  [(accessed on 23 July 2024)].  Available online:  https://rdocumentation.org/packages/haplo.stats/versions/1.9.3.</Citation></Reference><Reference><Citation>R Core Team . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; Vienna, Austria: 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>